Mantini, Giovanna
 Distribuzione geografica
Continente #
NA - Nord America 4.835
EU - Europa 3.832
AS - Asia 3.051
SA - Sud America 576
Continente sconosciuto - Info sul continente non disponibili 194
AF - Africa 86
OC - Oceania 20
AN - Antartide 1
Totale 12.595
Nazione #
US - Stati Uniti d'America 4.679
DE - Germania 1.527
SG - Singapore 1.418
CN - Cina 742
SE - Svezia 605
BR - Brasile 476
IT - Italia 331
FR - Francia 323
UA - Ucraina 278
VN - Vietnam 223
GB - Regno Unito 182
IN - India 171
IE - Irlanda 141
ID - Indonesia 100
CA - Canada 99
PL - Polonia 79
RU - Federazione Russa 79
FI - Finlandia 70
JP - Giappone 67
TR - Turchia 66
BE - Belgio 43
HK - Hong Kong 42
BD - Bangladesh 39
AR - Argentina 35
CZ - Repubblica Ceca 31
IQ - Iraq 31
NL - Olanda 30
MX - Messico 25
ES - Italia 22
ZA - Sudafrica 21
SA - Arabia Saudita 20
EC - Ecuador 18
AU - Australia 16
AT - Austria 15
CI - Costa d'Avorio 15
IR - Iran 14
JO - Giordania 14
UZ - Uzbekistan 14
CL - Cile 13
MA - Marocco 12
CH - Svizzera 11
TN - Tunisia 11
BZ - Belize 10
PK - Pakistan 10
PT - Portogallo 10
VE - Venezuela 10
AZ - Azerbaigian 9
PH - Filippine 9
CO - Colombia 8
EU - Europa 8
KE - Kenya 8
LT - Lituania 8
PE - Perù 8
AE - Emirati Arabi Uniti 7
KR - Corea 7
DK - Danimarca 5
DZ - Algeria 5
IL - Israele 5
KZ - Kazakistan 5
NO - Norvegia 5
TH - Thailandia 5
TT - Trinidad e Tobago 5
BG - Bulgaria 4
HU - Ungheria 4
JM - Giamaica 4
LB - Libano 4
MY - Malesia 4
NG - Nigeria 4
NP - Nepal 4
RO - Romania 4
RS - Serbia 4
BO - Bolivia 3
BY - Bielorussia 3
EG - Egitto 3
ET - Etiopia 3
GR - Grecia 3
HN - Honduras 3
KG - Kirghizistan 3
LK - Sri Lanka 3
LV - Lettonia 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BH - Bahrain 2
EE - Estonia 2
LU - Lussemburgo 2
MD - Moldavia 2
MN - Mongolia 2
PS - Palestinian Territory 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
A1 - Anonimo 1
AG - Antigua e Barbuda 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
Totale 12.395
Città #
Singapore 765
Chandler 666
Ashburn 469
San Jose 446
Jacksonville 158
Beijing 154
Ann Arbor 145
Dublin 140
San Mateo 138
Nanjing 107
The Dalles 106
Nürnberg 100
Dearborn 98
Houston 97
Jakarta 90
New York 85
Woodbridge 83
Lauterbourg 81
Wilmington 81
Los Angeles 77
Ho Chi Minh City 73
Boston 72
Munich 68
Frankfurt am Main 66
Warsaw 62
Hanoi 58
Redwood City 57
Tokyo 57
Marseille 53
São Paulo 52
Milan 50
Bremen 46
Nanchang 46
Cattolica 45
Fairfield 45
Izmir 44
Moscow 44
Princeton 44
Brussels 42
Dallas 39
Hong Kong 39
Santa Clara 39
Redmond 38
Hefei 37
Lawrence 37
Rome 35
Toronto 35
Buffalo 32
Paris 29
Seattle 29
Atlanta 23
Chicago 23
Hebei 22
Leawood 22
North York 22
Kunming 20
Shanghai 20
Tianjin 19
Hangzhou 18
Jiaxing 18
Shenyang 18
Helsinki 17
Boardman 16
London 16
Mountain View 16
San Francisco 16
Stockholm 16
Abidjan 15
Guangzhou 15
Phoenix 15
Amman 14
Brasília 14
Brooklyn 14
Düsseldorf 14
Hyderabad 14
Orem 14
Washington 14
Albuquerque 13
Rio de Janeiro 13
San Diego 13
Zhengzhou 13
Amsterdam 12
Enterprise 12
Tashkent 12
Andover 11
Changsha 11
Memphis 11
Ottawa 11
Belize City 10
Da Nang 10
Las Vegas 10
Baghdad 9
Belo Horizonte 9
Chennai 9
Falls Church 9
Fremont 9
Philadelphia 9
Quito 9
University Park 9
Baku 8
Totale 6.206
Nome #
Low-dose fractionated radiotherapy and concomitant chemotherapy in glioblastoma multiforme with poor prognosis: a feasibility study 319
Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial 301
EP-1325 Personalized Medicine in breast cancer: a nomogram from prognostic score to deescalate radiotherapy 294
Pros-IT CNR: an Italian prostate cancer monitoring project 285
Low-dose radiotherapy as a chemo-potentiator of a chemotherapy regimen with pemetrexed for recurrent non-small-cell lung cancer: a prospective phase II study. 284
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 240
Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies 230
Single-arm phase II study of conformal radiation therapy and temozolomide plus fractionated stereotactic conformal boost in high-grade gliomas: final report. 228
Reducing heart dose during left breast cancer radiotherapy: comparison among 3 radiation techniques 220
Adjuvant radiotherapy in non small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial. 214
Infusional 5-fluorouracil and ZD1839 (Gefitinib-Iressa) in combination with preoperative radiotherapy in patients with locally advanced rectal cancer: a phase I and II Trial (1839IL/0092) 208
Whole-brain radiotherapy combined with surgery or stereotactic radiotherapy in patients with brain oligometastases: long-term analysis. 207
Novel prognostic groups in thymic epithelial tumors: assessment of risk and therapeutic strategy selection. 205
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 202
Oncologic outcomes in advanced laryngeal squamous cell carcinomas treated with different modalities in a single institution: a retrospective analysis of 65 cases 200
A feasibility study of neo-adjuvant low-dose fractionated radiotherapy with two different concurrent anthracycline-docetaxel schedules in stage IIA/B-IIIA breast cancer 199
Oncotype DX Predictive Nomogram for Recurrence Score Output: The Novel System ADAPTED01 Based on Quantitative Immunochemistry Analysis 199
Intensity-modulated radiotherapy with simultaneous integrated boost to dominant intraprostatic lesion: preliminary report on toxicity 194
Concurrent and adjuvant temozolomide-based chemoradiotherapy schedules for glioblastoma. Hypotheses based on two prospective phase II trials 193
Radiotherapy and concomitant temozolomide during the first and last weeks in high grade gliomas: long-term analysis of a phase II study 190
Oncological outcome in advanced laryngeal cancers treated with different modalities in a single institution. A retrospective analysis on 65 cases. 186
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 178
External beam radiotherapy plus 24 hours continuous infusion of gemcitabine in unresectable pancreatic carcinoma: long term result of a phase II study 175
Radiotherapy vs Follow up in the treatment of pathological stage Ia and Ib non small cell lung cancer. Early stopped analysis of a randomized controlled study. 173
Reducing heart dose during left breast cancer radiotherapy: Comparison among 3 radiation techniques 173
Intraoperative radiation therapy in resected pancreatic carcinoma: long-term analysis. 171
Shoulder girdle impairment in breast cancer survivors: the role of range of motion as predictive factor for dose distribution and clinical outcome 168
Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy 166
Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: long-term experience 165
Low-dose radiotherapy as a chemo-potentiator of a chemotherapy regimen with pemetrexed for recurrent non-small-cell lung cancer: a prospective phase II study 165
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 164
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 163
Low-dose hyperradiosensitivity: is there a place for future investigation in clinical settings? 159
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 155
PRODIGE: PRediction models in prOstate cancer for personalized meDIcine challenGE 155
Targeted "bone-seeking" radiopharmaceuticals for palliative treatment of bone metastases: a systematic review and meta-analysis. 154
The predictive value of 18F-FDG PET-CT for assessing the clinical outcomes in locally advanced NSCLC patients after a new induction treatment: low-dose fractionated radiotherapy with concurrent chemotherapy. 153
Overview of potential determinants of radical prostatectomy versus radiation therapy in management of clinically localized prostate cancer: results from an Italian, prospective, observational study (the Pros-IT CNR study) 153
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study 152
Role of radiotherapy in the treatment of fibrosarcoma of the spermatic cord: a case report and review of the literature 151
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 150
[Radiotherapy in men with prostate cancer: indications, evolutions and integrated approaches] 144
Locally advanced prostate cancer: three-dimensional magnetic resonance spectroscopy to monitor prostate response to therapy 143
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 140
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 138
Locally Advanced Prostate Cancer: Three-Dimensional Magnetic Resonance Spectroscopy to Monitor Prostate Response to Therapy 138
Predictive Factors of Late-onset Rectal Mucosal Changes After Radiotherapy of Prostate Cancer 131
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 129
Locally advanced prostate cancer: three-dimensional magnetic resonance spectroscopy to monitor prostate response to therapy. 129
Can automation in radiotherapy reduce costs? 127
SPHINCTER PRESERVATION IN FOUR CONSECUTIVE PHASE II STUDIES OF PREOPERATIVE CHEMORADIATION: ANALYSIS OF 247 T3 RECTAL CANCER PATIENTS. 127
Radiotherapy in men with prostate cancer: indications, evolutions and integrated approaches 126
MITHRA - Multiparametric MR/CT image adapted brachytherapy (MR/CT-IABT) in anal canal cancer: A feasibility study 121
Tailored postoperative treatment of prostate cancer: final results of a phase I/II trial 119
PRODIGE: PRediction models in prOstate cancer for personalized meDIcine challenGE 119
OncotypeDX (R) predictive nomogram for recurrence score output: A machine learning system based on quantitative immunochemistry analysis-ADAPTED01 118
MR-guided radiotherapy in rectal cancer: First clinical experience of an innovative technology 117
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer 116
Beyond geometrical overlap: a Dosimetrical Evaluation of automated volumes Adaptation (DEA) in head and neck replanning 114
LONG-TERM RESULTS AFTER NEOADJUVANT RADIOCHEMOTHERAPY FOR LOCALLY ADVANCED RESECTABLE EXTRAPERITONEAL RECTAL CANCER. 112
The predictive value of 18F-FDG PET-CT for assessing the clinical outcomes in locally advanced NSCLC patients after a new induction treatment: Low-dose fractionated radiotherapy with concurrent chemotherapy 109
BIT-ART: Multicentric comparison of HDR-brachytherapy, intensity-modulated radiotherapy and tomotherapy for advanced radiotherapy in prostate cancer 108
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer 107
Percutaneous radiofrequency ablation using internally cooled wet electrodes for the treatment of patients with lung tumors 103
Simultaneous integrated radiotherapy boost to the dominant intraprostatic lesion: Final results of a phase I/II trial 103
Proficiency testing of first- and second-line anti-tuberculosis drugs in Italy 102
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer 102
Breakthrough pain management in patients undergoing radiotherapy: A national survey on behalf of the Palliative and Supportive Care Study Group 101
Locoregional pain treatment. Troubles and prospectives: antalgic radiotherapy 100
Adaptive optimization by 6 DOF robotic couch in prostate volumetric IMRT treatment: Rototranslational shift and dosimetric consequences 97
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 96
Radiotherapy plus GnRH analogue versus high dose bicalutamide: A case control study 95
Preoperative chemoradiation and intra-operative radiotherapy for pancreatic carcinoma 92
776 poster THE PRELIMINARY RESULTS OF PHASE II STUDY: NEOADJUVANT CHEMOTHERAPY AND LOW-DOSE RADIOTHERAPY FOR BREAST CANCER 86
Oncotype DX Predictive Nomogram for Recurrence Score Output: The Novel System ADAPTED01 Based on Quantitative Immunochemistry Analysis 83
Impact of dose and volume on radiation-induced mucositis 77
External beam radiotherapy plus 24-hour continuous infusion of gemcitabine in unresectable pancreatic carcinoma: long-term results of a phase II study 74
Prevalence of Cardiovascular Disease and Osteoporosis During Androgen Deprivation Therapy Prescription Discordant to EAU Guidelines: Results From a Multicenter, Cross-sectional Analysis From the CHOsIng Treatment for Prostate canCEr (CHOICE) Study 72
Patterns of prescription and adherence to European Association of Urology guidelines on androgen deprivation therapy in prostate cancer: An Italian multicentre cross-sectional analysis from the Choosing Treatment for Prostate Cancer (CHOICE) study 71
Health-related quality of life 24 months after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational study 68
Split course concomitant radiochemotherapy followed by brachytherapy boost in the exclusive treatment of the anal canal cancer 57
Spider: Managing clinical data of cancer patients treated through a multidisciplinary approach by a palm based system 54
Chemoradiation with raltitrexed (TOMUDEX) in preoperative treatment of stage II-III resectable rectal cancer: A phase II study 52
Preoperative radiotherapy in gastric cancer: CTV definition for conformal therapy according to tumor location 51
Quality handbook in radiotherapy: personal experience 45
The cardiokine secreted Frizzled-related protein 3, a modulator of Wnt signalling, in clinical and experimental heart failure 41
Totale 12.595
Categoria #
all - tutte 49.053
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.053


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022772 0 57 16 58 52 45 27 134 34 67 132 150
2022/20231.770 254 250 149 303 102 208 88 126 203 13 47 27
2023/2024724 33 207 20 69 29 95 16 55 11 22 78 89
2024/20251.541 49 49 118 55 149 41 26 72 250 151 324 257
2025/20263.617 592 96 188 345 672 178 638 195 273 244 108 88
2026/2027340 106 234 0 0 0 0 0 0 0 0 0 0
Totale 12.595